Nobiletin Acts As a Potential Anticancer Agent Against Osteosarcoma by Regulating ERK and AKT Signaling Pathways. Bangladesh J Pharmacol 2014, 9 (3), 406-412. https://doi.org/10.3329/bjp.v9i3.19567.